The Gender Gap Cracks Under Pressure: A Detailed Look at Male and Female Performance Differences During Competitions

Using data from multiple-period math competitions, we show that males outperform females of similar ability during the first period. However, the male advantage is not found in any subsequent period of competition, or even after a two-week break from competition. Some evidence suggests that males may actually perform worse than females in later periods. The analysis considers various experimental treatments and finds that the existence of gender differences depends crucially on the design of the competition and the task at hand. Even when the male advantage does exist, it does not persist beyond the initial period of competition.competitiveness, gender differences, effort and productivity, field experiment

Causes of Gender Differences in Competition: Theory and Evidence

We use a game theoretic model of contests to assess different explanations for the male performance advantage in competition. Comparing the testable predictions of the model with the empirical evidence, we reject explanations involving male overcon- fidence, misperceptions about relative ability, and some preference differences. Ex- planations involving female underconfidence, stereotype threat, and adverse female reaction to competition are consistent with only some of the evidence, and an expla- nation involving lower male risk aversion is consistent with most of the evidence. Two explanations are consistent with all of the evidence: (i) male ability to perform may in- crease in the face of competition, possibly due to changes in testosterone or adrenaline; or (ii) males may care more about winning or get greater enjoyment from competition than females.contests, gender differences, effort and productivity

Partnerships for education, well-being and work : models of university service in the community

"This five month multi-perspective study, commissioned by the Higher Education Funding Council for England (HEFCE), investigated the nature, forms and practices of three partnership enterprises between the University of Nottingham and its local schools and communities" -- page vii

Chromium: Rise and Shine in Peritoneal Dialysis Patients?

Some trace elements are altered with chronic kidney disease. Selenium, zinc, and manganese tend to be wasted, and there is growing evidence that selenium deficiency is associated with mortality on dialysis. Other trace elements accumulate, such as chromium, cobalt, lead, molybdenum, and vanadium. The highest chromium levels are found in dialysis patients. The dialysis modality may further affect these levels, especially in hemodialysis patients, where even small contaminations in the dialysis feed water may lead to a concentration gradient that increases the concentration of certain trace elements. Chromium levels in peritoneal dialysis (PD) patients have been understudied. A single cross-sectional study found substantially higher chromium levels in PD patients. In that study, the chromium concentration in the spent dialysate decreased substantially, suggesting that PD fluid could be a source of chromium. Chromium-lactate complexes may have been formed, which are easily absorbed. In our center, we observed a decrease in chromium level when using physiological PD fluids. This review discusses the potential mechanisms and raises the question of whether this accumulation of chromium is unlikely to be associated with a beneficial outcome

Determinants of change in arterial stiffness over 5 years in early chronic kidney disease

BackgroundArterial stiffness is an established and potentially modifiable risk factor for cardiovascular disease, associated with chronic kidney disease. There have been few studies to evaluate progression of arterial stiffness over time or factors that contribute to this, particularly in early chronic kidney disease. We therefore investigated arterial stiffness over 5 years in an elderly population with chronic kidney disease stage 3, cared for in primary care.Methods1741 persons with estimated GFR 30-59mL/min/1.73m2 underwent detailed clinical and biochemical assessment at baseline, year 1 and 5. Carotid to femoral pulse wave velocity (PWV) was measured to assess arterial stiffness using a Vicorder™ device.Results970 participants had PWV assessments at baseline and 5 years. PWV increased significantly by a mean of 1.1 m/s (from 9.7±1.9 to 10.8±2.1m/s). Multivariable linear regression analysis identified the following independent determinants of ΔPWV at year 5: baseline age, diabetes status, baseline systolic and diastolic blood pressure (BP), baseline PWV, ΔPWV at one year, Δ systolic BP over 5 years and Δ serum bicarbonate over 5 years (R2=0.38 for equation).ConclusionsWe observed a clinically significant increase in PWV over 5 years in a cohort with early chronic kidney disease despite reasonably well controlled hypertension. Measures of blood pressure were identified as the most important modifiable determinant of change in PWV suggesting that interventions to prevent arterial disease should focus on improved control of blood pressure, particularly in those who evidence an early increase in PWV. These hypotheses should now be tested in prospective trials

2015 Fine Art Graduation Exhibition Catalogue

Graduation Exhibition 2015 Fanshawe College Fine Art Program The Arts ProjectApril 8-18, 2015 Opening ReceptionSaturday April 11, 20157pm-10pm Guest SpeakerJennifer SimaitisMembership Coordinator: The Power Plant Gallery Torontohttps://first.fanshawec.ca/famd_design_fineart_gradcatalogues/1010/thumbnail.jp

Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3

Objectives Vitamin D deficiency, elevated fibroblast growth factor 23 (FGF23) and elevated parathyroid hormone (PTH) have each been associated with increased mortality in people with chronic kidney disease (CKD). Previous studies have focused on the effects of FGF23 in relatively advanced CKD. This study aims to assess whether FGF23 is similarly a risk factor in people with early CKD, and how this risk compares to that associated with vitamin D deficiency or elevated PTH. Design Prospective cohort study. Setting Thirty-two primary care practices. Participants One thousand six hundred and sixty-four people who met Kidney Disease: Improving Global Outcomes (KDIGO) definitions for CKD stage 3 (two measurements of estimated glomerular filtration rate (eGFR) between 30 and 60 mL/min/1.73 m2 at least 90 days apart) prior to study recruitment. Outcome measures All-cause mortality over the period of study follow-up and progression of CKD defined as a 25% fall in eGFR and a drop in GFR category, or an increase in albuminuria category. Results Two hundred and eighty-nine participants died during the follow-up period. Vitamin D deficiency (HR 1.62, 95% CI 1.01 to 2.58) and elevated PTH (HR 1.42, 95% CI 1.09 to 1.84) were independently associated with all-cause mortality. FGF23 was associated with all-cause mortality in univariable but not multivariable analysis. Fully adjusted multivariable models of CKD progression showed no association with FGF23, vitamin D status or PTH. Conclusions In this cohort of predominantly older people with CKD stage 3 and low risk of progression, vitamin D deficiency and elevated PTH were independent risk factors for all-cause mortality but elevated FGF23 was not. While FGF23 may have a role as a risk marker in high-risk populations managed in secondary care, our data suggest that it may not be as important in CKD stage 3, managed in primary care

Chronic kidney disease in primary care: outcomes after five years in a prospective cohort study

Background Chronic kidney disease (CKD) is commonly managed in primary care, but most guidelines have a secondary care perspective emphasizing the risk of end-stage kidney disease (ESKD) and need for renal replacement therapy. In this prospective cohort study, we sought to study in detail the natural history of CKD in primary care to better inform the appropriate emphasis for future guidance. Methods and Findings In this study, 1,741 people with CKD stage 3 were individually recruited from 32 primary care practices in Derbyshire, United Kingdom. Study visits were undertaken at baseline, year 1, and year 5. Binomial logistic regression and Cox proportional hazards models were used to model progression, CKD remission, and all-cause mortality. We used Kidney Disease: Improving Global Outcomes (KDIGO) criteria to define CKD progression and defined CKD remission as the absence of diagnostic criteria (estimated glomerular filtration rate [eGFR] >60 ml/min/1.73 m2 and urine albumin-to-creatinine ratio [uACR] <3 mg/mmol) at any study visit. Participants were predominantly elderly (mean ± standard deviation (SD) age 72.9 ± 9.0 y), with relatively mild reduction in GFR (mean ± SD eGFR 53.5 ± 11.8 mL/min/1,73 m2) and a low prevalence of albuminuria (16.9%). After 5 y, 247 participants (14.2%) had died, most of cardiovascular causes. Only 4 (0.2%) developed ESKD, but 308 (17.7%) evidenced CKD progression by KDIGO criteria. Stable CKD was observed in 593 participants (34.1%), and 336 (19.3%) met the criteria for remission. Remission at baseline and year 1 was associated with a high likelihood of remission at year 5 (odds ratio [OR] = 23.6, 95% CI 16.5–33.9 relative to participants with no remission at baseline and year 1 study visits). Multivariable analyses confirmed eGFR and albuminuria as key risk factors for predicting adverse as well as positive outcomes. Limitations of this study include reliance on GFR estimated using the Modification of Diet in Renal Disease study (MDRD) equation for recruitment (but not subsequent analysis) and a study population that was predominantly elderly and white, implying that the results may not be directly applicable to younger populations of more diverse ethnicity. Conclusions Management of CKD in primary care should focus principally on identifying the minority of people at high risk of adverse outcomes, to allow intervention to slow CKD progression and reduce cardiovascular events. Efforts should also be made to identify and reassure the majority who are at low risk of progression to ESKD. Consideration should be given to adopting an age-calibrated definition of CKD to avoid labelling a large group of people with age-related decline in GFR and low associated risk as having CKD

Confinement of the Sun's interior magnetic field: some exact boundary-layer solutions

High-latitude laminar confinement of the Sun's interior magnetic field is shown to be possible, as originally proposed by Gough and McIntyre (1998) but contrary to a recent claim by Brun and Zahn (A&A 2006). Mean downwelling as weak as 2x10^-6cm/s -- gyroscopically pumped by turbulent stresses in the overlying convection zone and/or tachocline -- can hold the field in advective-diffusive balance within a confinement layer of thickness scale ~ 1.5Mm ~ 0.002 x (solar radius) while transmitting a retrograde torque to the Ferraro-constrained interior. The confinement layer sits at the base of the high-latitude tachocline, near the top of the radiative envelope and just above the `tachopause' marking the top of the helium settling layer. A family of exact, laminar, frictionless, axisymmetric confinement-layer solutions is obtained for uniform downwelling in the limit of strong rotation and stratification. A scale analysis shows that the flow is dynamically stable and the assumption of laminar flow realistic. The solution remains valid for downwelling values of the order of 10^-5cm/s but not much larger. This suggests that the confinement layer may be unable to accept a much larger mass throughput. Such a restriction would imply an upper limit on possible internal field strengths, perhaps of the order of hundreds of gauss, and would have implications also for ventilation and lithium burning. The solutions have interesting chirality properties not mentioned in the paper owing to space restrictions, but described at http://www.atmos-dynamics.damtp.cam.ac.uk/people/mem/papers/SQBO/solarfigure.htmlComment: 6 pages, 3 figures, to appear in conference proceedings: Unsolved Problems in Stellar Physic

The limits of simulating gas giant entry at true gas composition and true flight velocities in an expansion tube

Due to high entry velocities when entering gas giant planets in the solar system (20-50 km/s), simulating gas giant entry in ground testing facilities is a complex problem. This paper details an investigation to simulate radiating Uranus entry flow conditions in a superorbital expansion tube facility. Theoretical calculations show that the X2 expansion tube at the University of Queensland can simulate Uranus entry at 20 km/s. This paper provides the justification for an experimental campaign that has been partially completed, but is still being analysed